(Q38459057)

3 September 2017

title

DNA topoisomerase IIalpha expression correlates with cell proliferation but not with recurrence in intracranial meningiomas (English)

1 reference

3 September 2017

Konstantinidou AE

1

1 reference

3 September 2017

Patsouris E

2

1 reference

3 September 2017

Korkolopoulou P

3

1 reference

3 September 2017

Kavantzas N

4

1 reference

3 September 2017

Mahera H

5

1 reference

3 September 2017

Davaris P

6

1 reference

3 September 2017

publication date

1 October 2001

1 reference

3 September 2017

1 reference

3 September 2017

volume

39

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

402-408

1 reference

Meningioma: analysis of recurrence and progression following neurosurgical resection

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

Development of a clonogenic cell assay for human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

Review of basic concepts of cell kinetics as applied to brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

Meningioma: proliferating potential and clinicoradiological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

Structure and function of type II DNA topoisomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

Brain-tumor cell kinetics correlated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01229.X

10.1046/J.1365-2559.2001.01229.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference